Physician profile
Ranjit Singh Makar
NPI 1083858997
$6,102.02
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,610 · 2020: $1,036 · 2021: $1,105 · 2022: $227 · 2023: $1,038 · 2024: $86.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $858 · Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $857.62 |
| Food and Beverage | $267.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,315.58 | 2019-2024 | Exalt Model D |
| Ovesco Endoscopy USA, INC. | $857.62 | 2023 | |
| Abbvie INC. | $391.56 | 2019-2023 | |
| Janssen Biotech, INC. | $328.00 | 2020-2022 | |
| Cook Medical LLC | $294.89 | 2019 | |
| Gilead Sciences, INC. | $185.14 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.58 | 2021 | |
| Nestle Healthcare Nutrition INC. | $129.54 | 2021 | |
| Fujifilm Wako Diagnostics U.S.A. Corporation | $100.53 | 2019 | |
| Qol Medical, LLC | $72.49 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.29 | 2021 | |
| Ferring Pharmaceuticals INC. | $47.75 | 2020-2021 | |
| Intra-Sana Laboratories | $41.65 | 2021 | |
| Redhill Biopharma INC. | $39.78 | 2020-2021 | |
| Eisai INC. | $33.02 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $17.28 | 2021 | |
| Braintree Laboratories, INC. | $15.58 | 2021 | |
| Merck Sharp & Dohme LLC | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjit Makar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.